Blood protein tied to Alzheimer’s disease risk
NEW YORK (Reuters Health) - Low levels of cystatin C — a blood protein commonly used as a measure of kidney function — may be a risk factor for the development of Alzheimer’s disease in elderly men, researchers report.
Cystatin C is produced by nearly all human cells and available in all body fluids. During the past decade, studies have suggested that cystatin C activity in the brain may protect against the development of Alzheimer’s disease by inhibiting amyloid-beta — a protein in the body that forms amyloid plaques in the brain, a key feature of Alzheimer’s disease.
To further explore this idea, Dr. Johan Sundelof, of Uppsala University, Sweden, and colleagues examined the association between blood levels of cystatin C and the development of Alzheimer’s disease in a group of 1,230 men in their early 70s, who were re-assessed when they were about 77 years old.
A total of 82 subjects were diagnosed with Alzheimer’s disease during follow-up.
The researchers observed an association between lower cystatin C levels and higher risk of Alzheimer’s disease.
According to the researchers, a 0.1-mcmol/L decrease of cystatin C between ages 70 and 77 was associated with a 29 percent higher risk of developing Alzheimer’s disease.
“Our findings strengthen the evidence of a role for cystatin C in Alzheimer’s disease pathogenesis,” Sundelof said in an interview with Reuters Health.
SOURCE: Neurology, September 30, 2008.
--------------------------------------------------------------------------------------------Related Posts:
By Will Dunham WASHINGTON (Reuters) - Brain scans of people with an abnormality that is a hallmark of Alzheimer’s disease are strengthening the notion that greater education levels somehow protect against this common form of dementia. People with more education did better on memory and problem solving tests than others with similar amounts of brain plaques related
Full Post: Education blunts effects of Alzheimer’s: study
--------------------------------------------------------------------------------------------
By Will Dunham WASHINGTON (Reuters) - High doses of B vitamins failed to slow cognitive decline in people with Alzheimer’s disease, dashing the hopes for a new weapon against the fatal, mind-robbing ailment, U.S. researchers said on Tuesday. Experts had viewed B vitamins as a potential way to lower the risk of Alzheimer’s disease or slow its
Full Post: B vitamins fail in U.S. Alzheimer’s disease study
--------------------------------------------------------------------------------------------
LONDON (Reuters) - Mice fed junk food for nine months showed signs of developing the abnormal brain tangles strongly associated with Alzheimer’s disease, a Swedish researcher said on Friday. The findings, which come from a series of published papers by a researcher at Sweden’s Karolinska Institutet, show how a diet rich in fat, sugar and cholesterol
Full Post: Research on mice links fast food to Alzheimer’s
--------------------------------------------------------------------------------------------
NEW YORK (Reuters Health) - Women who are heavy in their middle years are at greater risk of Alzheimer’s disease, especially if they have large waists. However, for men, being underweight during that period of life actually increases the likelihood of developing the degenerative brain disease, researchers report in the American Journal of Epidemiology. In addition,
Full Post: Weight-Alzheimer link different for men and women
--------------------------------------------------------------------------------------------
LONDON (Reuters) - A slow, chronic reduction of blood sugar to the brain could trigger some forms of Alzheimer’s disease, U.S. researchers said on Wednesday. The study of human and mice brains suggests a reduction of blood flow deprives energy to the brain, setting off a process that ultimately produces the sticky clumps of protein researchers
Full Post: Blood sugar loss may trigger Alzheimer’s: study